Events

Retiro De Equipo (Recall) de MVU percuflex stent

Según Pharmaceuticals and Medical Devices Agency, Japan, este evento ( retiro de equipo (recall) ) involucró a un dispositivo médico en Japan que fue producido por Boston Scientific Japan Co., Ltd..

¿Qué es esto?

Una corrección al equipo o acción de retiro tomada por el fabricante para abordar un problema con un dispositivo médico. Los retiros (recalls) ocurren cuando un dispositivo médico está defectuoso, cuando puede poner en riesgo la salud, o cuando simultáneamente está defectuoso y puede poner en riesgo la salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall
  • ID del evento
    2-7208
  • Fecha
    2016-11-28
  • País del evento
    Japan
  • Fuente del evento
    PMDAJ
  • URL de la fuente del evento
    http://www.info.pmda.go.jp/rgo/MainServlet?recallno=2-7208
  • Notas / Alertas
    Japanese data is current through August 2018. All of the data comes from the Japanese Pharmaceuticals and Medical Devices Agency, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Japan.
  • Notas adicionales en la data

Device

MVU percuflex stent

Manufacturer

Boston Scientific Japan Co., Ltd.
  • Empresa matriz del fabricante (2017)
    Boston Scientific
  • Comentario del fabricante
    “We take a patient-first approach to assessing the applicability of every recall and communicate to regulatory bodies in all geographies where the recalled device is sold,” Boston Scientific said in a statement to ICIJ. “We have coordinated several recalls across many countries in a timely manner,” the company said, adding that it complies with all national laws, which can often vary and require different processes for reporting information or taking action on recalls. The company said it uses a rigorous and uniform process to take action on recalls and that “when we initiate a field action (e.g. recall, safety alert), every customer who has received an affected product receives a communication that includes a letter for the physician.”
  • Source
    PMDAJ